TITLE

What we might know when START's finished

PUB. DATE
September 2008
SOURCE
Research Initiative/Treatment Action!;Autumn2008, Vol. 13 Issue 2, p25
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the Strategies for Timing of Antiretroviral Treatment (START), a randomized trial for HIV-infected patients. It aims to determine whether patients should begin therapy while their CD4 T-cells are still above 500 cells mm3 or wait until the count falls to 350 cells mm3. It also includes START three secondary objectives such comparison of early and deferred antiretroviral therapy (ART) for each of the primary composite outcome's component.
ACCESSION #
51533071

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics